Mullins v. Clear

CourtDistrict Court, W.D. Virginia
DecidedSeptember 29, 2021
Docket7:20-cv-00573
StatusUnknown

This text of Mullins v. Clear (Mullins v. Clear) is published on Counsel Stack Legal Research, covering District Court, W.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mullins v. Clear, (W.D. Va. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF VIRGINIA ROANOKE DIVISION

EUGENE MCAUTHUR MULLINS, ) ) Plaintiff, ) Civil Action No. 7:20-cv-00573 ) v. ) MEMORANDUM OPINION ) STEPHEN CLEAR, et al., ) By: Hon. Thomas T. Cullen ) United States District Judge Defendants. )

Eugene McAuthur Mullins, a Virginia inmate proceeding pro se, filed this civil action under 42 U.S.C. § 1983 against Stephen Clear and Howard Carlton (collectively “Defendants”). Mullins claims that the defendants violated his constitutional right to receive adequate medical care while incarcerated. The case is presently before the court on Defendants’ motions for summary judgment. For the reasons set forth below, the motions will be granted. I. FACTUAL BACKGROUND The following facts are either undisputed or presented in the light most favorable to Mullins, the nonmoving party on summary judgment. See Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 255 (1986). Clear is the Superintendent of the Southwest Virginia Regional Jail Authority (“SWVRJA”). (Pl.’s Add’l Evid. at 181 [ECF No. 29].) Carlton is a registered nurse and Health

1 The page numbers in the court’s citations to the parties’ exhibits refer to those assigned by the CM/ECF system. Services Administrator. (Aff. of Howard Carlton ¶ 2, Dec. 1, 2020 [ECF No. 18-1].) Carlton “work[s] with Mediko Correctional Healthcare as an independent contractor to provide nursing care and administrative services to inmates at [the SWVRJA’s] Abingdon facility.” (Id.)

Mullins has been in the custody of the SWVRJA since January 23, 2020. (Id. ¶ 6.) Upon his arrival at the Abingdon facility, a licensed practical nurse performed an intake screening. (Carlton Aff. Ex. at 37–44 [ECF No. 18-2].) During the intake screening, Mullins reported that he had a history of seizures and that he was currently taking gabapentin and other medications. (Id. at 37, 41.) Mullins also reported that he had been using methamphetamine and opioids on a daily basis for six or seven months and that he had recently used intravenous

drugs. (Id. at 41–42.) Based on his reported drug use and the potential for withdrawal, Mullins was admitted to the medical observation unit (“MOU”) for monitoring. (Id. at 14.) He was released from the MOU on January 27, 2020, after exhibiting no signs or symptoms of withdrawal. (Id.) On February 1, 2020, Mullins submitted a medical request for his prescribed medications. (Pl.’s Resp. in Opp’n at 3 [ECF No. 26].) Mullins provided the name of a

pharmacy that might be able to provide the required information. (Id.) On February 2, 2020, a nurse went to Mullins’s cell to assess him for chest and shoulder pain. (Carlton Aff. Ex. at 14.) Mullins reported that he had fallen the previous night while having a seizure. (Id.) He advised the nurse that he had been prescribed gabapentin for seizures and that he needed the medication. (Id.) The nurse moved Mullins to the MOU to “monitor for seizure activity” and placed him on the list to see a doctor. (Id.) The next day, Mullins asked

- 2 - to be released from the MOU. (Id. at 56.) He reported that a visitor was coming to see him and that he was feeling better. (Id.at 56–57.) On February 5, 2020, Mullins saw Dr. Joseph Cutchin. (Id. at 25.) The examination

notes indicate that Mullins requested gabapentin. (Id.) Because of its addictive properties and potential for abuse, gabapentin is not dispensed at the Abingdon facility. (Carlton Aff. ¶ 9.) Consequently, “Dr. Cutchin ordered Keppra [levetiracetam], an anti-convulsant with fewer addictive properties.”2 (Id.; see also Carlton Aff. Ex. at 25.) That same day, a family member delivered six additional prescription medications, each of which was tabulated and ordered for Mullins. (Id. at 25–29.) On February 6, 2020, Mullins’s prescription for Keppra arrived at the

facility, and he received his first dose. (Id. at 29.) On March 16, 2020, Mullins submitted a medical grievance regarding his previous fall. (Pl.’s Resp. in Opp’n at 36.) Mullins asserted that he “had a seizure and fell off the top bunk” because he had gone “without [his] seizure meds . . . for 13 days.” (Id.) That same day, Mullins submitted a request for medical treatment. (Id. at 37.) He reported experiencing pain in his neck, shoulder, and back as a result of the fall. (Id.) A medical staff member responded that

Mullins was already assigned to a bottom bunk and that he would be placed on the list to see a doctor. (Id.) The staff member also explained that outside medications cannot be given to inmates without “medical records” or “current pill bottles.” (Id. at 36.) On March 19, 2020, Mullins submitted a medical grievance concerning his initial bunk assignment and the delay in receiving seizure medication. (Id. at 40.) In response, a medical

2 Keppra is the brand name for levetiracetam. See Arellano v. Santos, No. 3:18-cv-02391, 2020 WL 1275650, at *4 n.2 (S.D. Cal. Mar. 16, 2020) (internal citation omitted). - 3 - staff member noted that Mullins had been prescribed Keppra for seizures and that he had been assigned to a bottom bunk. (Id.) On March 26, 2020, Mullins submitted another medical grievance raising similar

complaints. (Pl.’s Add’l Evid. at 4.) In response, a medical staff member once again noted that Dr. Cutchin had ordered Keppra for seizures and that Mullins had been designated for placement on a bottom bunk. (Id.) The staff member also noted that outside medical records forwarded to the facility made no mention of Mullins being prescribed gabapentin. (Id.) On April 17, 2020, Mullins was examined by Dr. Troy Reece. (Carlton Aff. Ex. at 23.) The examination notes indicate that Mullins complained of shoulder pain from a previous

injury. (Id.) Based on the physical examination findings, Dr. Reece diagnosed Mullins with left shoulder impingement syndrome and administered an injection of Kenalog with lidocaine. (Id.) On April 27, 2020, Mullins submitted a request to see a doctor for ongoing shoulder and neck pain. (Pl.’s Resp. in Opp’n at 20.) A medical staff member advised Mullins that he would be placed on the list to see a doctor. (Id.)

Less than two weeks later, on May 5, 2020, Mullins saw Dr. Charles Hurlburt. (Carlton Aff. Ex. at 22.) During the examination, Mullins complained of worsening shoulder pain and reported that the steroid injection had not provided any relief. (Id.) Dr. Hurlburt prescribed Zanaflex and ordered an x-ray of Mullins’s left shoulder. (Id. at 23.) Carlton entered the orders from Dr. Hurlburt but did personally examine Carlton. (Id.; see also Carlton Aff. ¶ 5 (“I have never examined [Mullins] or been involved in any of his treatment decisions. My name appears

- 4 - only once in the medical records, when I input the orders from a physician’s visit . . . on May 5, 2020.”). Mullins underwent the shoulder x-ray that same day. (Carlton Aff. Ex. at 49.) The x-

ray revealed moderate arthritic changes but did not show evidence of fracture or dislocation. (Id.) The interpreting physician diagnosed Mullins with “[o]steoarthritis of the shoulder and A.C. joint space.” (Id.) On May 18, 2020, Mullins again requested to see a doctor for shoulder pain. (Pl.’s Resp. in Opp’n at 10.) In response, a medical staff member advised Mullins that Dr. Hurlburt wanted him to try Zanaflex for 30 days. (Id.) The staff member noted that Mullins had only been

taking the medication for approximately two weeks. (Id.) On May 27, 2020, Mullins saw Dr. Virat Bakhshi for various issues, including shoulder and neck pain. (Carlton Aff. Ex. at 20.) Dr. Bakhshi noted that Mullins had “left shoulder bursitis vs.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Belcher v. Oliver
898 F.2d 32 (Fourth Circuit, 1990)
New Zealand Lamb Company, Inc. v. United States
40 F.3d 377 (Federal Circuit, 1994)
George F. Thompson v. Potomac Electric Power Company
312 F.3d 645 (Fourth Circuit, 2002)
Libertarian Party of Virginia v. Charles Judd
718 F.3d 308 (Fourth Circuit, 2013)
Iko v. Shreve
535 F.3d 225 (Fourth Circuit, 2008)
Larry Green v. Theodis Beck
539 F. App'x 78 (Fourth Circuit, 2013)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Tolan v. Cotton
134 S. Ct. 1861 (Supreme Court, 2014)
Denise Wilkins v. Vicki Montgomery
751 F.3d 214 (Fourth Circuit, 2014)
Samuel Jackson v. Joseph Lightsey
775 F.3d 170 (Fourth Circuit, 2014)
Kingsley v. Hendrickson
576 U.S. 389 (Supreme Court, 2015)
Heyer v. United States Bureau of Prisons
849 F.3d 202 (Fourth Circuit, 2017)
Antonio Pearson v. Prison Health Service
850 F.3d 526 (Third Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Mullins v. Clear, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mullins-v-clear-vawd-2021.